Last €1.21 EUR
Change Today 0.00 / 0.00%
Volume 0.0
N6V On Other Exchanges
As of 4:00 PM 04/7/14 All times are local (Market data is delayed by at least 15 minutes).

n-viro international corp (N6V) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for N-VIRO INTERNATIONAL CORP (N6V)

Related News

No related news articles were found.

n-viro international corp (N6V) Related Businessweek News

No Related Businessweek News Found

n-viro international corp (N6V) Details

N-Viro International Corporation owns and licenses various N-Viro processes and patented technologies to treat and recycle wastewater and other bio-organic wastes, utilizing alkaline and mineral by-products produced by cement, lime, electrical generation, and other industries. Its N-Viro Process stabilizes and pasteurizes the wastewater residuals; reduces odors to acceptable levels; neutralizes or immobilizes various constituents; and generates N-Viro Soil, a product that has a granular appearance similar to soil and is used in various agricultural applications. The company also offers N-Viro Fuel, a patented biomass alternative energy fuel process, which produces a product that has physical and chemical characteristics similar to certain coals and is created from municipal biosolids, collectable animal manure, pulp and paper sludge, and other organic wastes. In addition, it is involved in the distribution and resale of alkaline admixtures for others. N-Viro International Corporation was founded in 1979 and is based in Toledo, Ohio.

19 Employees
Last Reported Date: 06/2/14
Founded in 1979

n-viro international corp (N6V) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $150.0K
Chief Financial Officer, Secretary and Treasu...
Total Annual Compensation: $125.0K
Executive Vice President and General Counsel
Total Annual Compensation: $150.0K
Compensation as of Fiscal Year 2013.

n-viro international corp (N6V) Key Developments

N-Viro International Corp. announced delayed 10-Q filing

On 05/16/2014, N-Viro International Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

N-Viro International Corp. Appoints Gene Richard to the Board of Directors as a Class II Director

N-Viro International Corp. announced that at a meeting of the Board of Directors on April 16, 2014, the company appointed Dr. Gene Richard to the Board of Directors as a Class II director, effective until the company's annual meeting to be held later in 2014. Dr. Richard has not yet been appointed to any committees as of the date of this filing, and is the son of a current member of the Board, Carl Richard. Dr. Richard is currently an Associate Pathologist with Consultants in Laboratory Med icine of Greater Toledo, Ohio, and has an extensive background in clinical and anatomic pathology, having practiced in Fort Wayne, Dallas and Toledo, and specializes in surgical pathology and cytopathology.

N-Viro International Corp. Announces Board Appointments

At a meeting of the Board of Directors on April 2, 2014, N-Viro International Corporation appointed Mr. Michael Burton-Prateley to the Board of Directors as a Class I director, effective until the company's annual meeting to be held in 2015. Mr. Burton-Prateley has not yet been appointed to any committees as of the date of this filing. Mr. Burton-Prateley is currently a member of the Executive Team" of BBM Energy, headquartered in London, England, and has an extensive background within the investment-banking sector. Also at the meeting, Mr. Joseph Giulii of Philadelphia, Pennsylvania was appointed a consultant to the Finance Committee of the Board of Directors, effective immediately and to be utilized on an as needed basis. Mr. Giulii is a reporting person to the Company and has filed a Form 13G, most recently on March 11, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
N6V:GR €1.21 EUR 0.00

N6V Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for N6V.
View Industry Companies

Industry Analysis


Industry Average

Valuation N6V Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N-VIRO INTERNATIONAL CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at